1 min read
Heron Therapeutics Sets Nov. 9 Call to Report Third-Quarter Results
The webcast is scheduled for 8:30 a.m. ET (13:30 UTC) and will also cover recent business highlights.

Heron Therapeutics, Inc. will hold a conference call and webcast at 8:30 a.m. ET Monday, Nov. 9, to report its third-quarter 2026 financial results and discuss recent business highlights.
The commercial-stage biotechnology company develops and commercializes therapies for acute care and oncology patients.